SK

Sreehari Kumar Annamraju

Active Director Managing Director DIN 08613870
DIN 08613870 First appointment Nov 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Nov 2019
Shareholding value •••• Premium profile

About Sreehari Kumar Annamraju

Data last updated:

Sreehari Kumar Annamraju is a Managing Director at Citizenplus Pharmaceuticals Private Limited (since 2019), Director at X Technology Private Limited (since 2025) and Director at Lexaro Laboratories Private Limited (since 2023), and holds 2 more current directorships. The companies operate in Pharma, Transportation and Infrastructure and Utilities. The largest current company by reported revenue is Citizenplus Pharmaceuticals Private Limited at ₹15.21 Cr (FY 2022). Earlier, Sreehari Kumar Annamraju was an Additional Director at Vani Pharma Labs Limited (2023).

DIN 08613870
Primary Designation Managing Director
Industry Pharma
First Appointment 19 Nov 2019
Oldest Company Age 11 yrs
Largest company Citizenplus Pharmaceuticals Private Limited · ₹15.21 Cr (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director19 Nov 20192015₹15.21 Cr (FY 2022)Active
X Technology Private Limited U82990KA2025PTC209191
Director30 Sep 20252025Active
Lexaro Laboratories Private Limited U46497TS2023PTC173272
Director19 May 20232023Active
Director13 Apr 20232023Active
Annamraju Infra Private Limited U45400TG2020PTC145606
Director05 Nov 20202020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vani Pharma Labs Limited U24110TG1976PLC002040
Additional Director18 Aug 20231976₹52.60 Cr (FY 2020)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Citizenplus Pharmaceuticals Private Limited
Annamraju Infra Private Limited
Saradyuthi Likhita Broadcasting Private Limited
Lexaro Laboratories Private Limited
Premium access

Shareholding and investment profile for Sreehari Kumar Annamraju

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sreehari Kumar Annamraju

Sreehari Kumar Annamraju currently holds 5 directorships: Citizenplus Pharmaceuticals Private Limited (Managing Director, since 19 Nov 2019, revenue ₹15.21 Cr (FY 2022)); X Technology Private Limited (Director, since 30 Sep 2025); Lexaro Laboratories Private Limited (Director, since 19 May 2023); Saradyuthi Likhita Broadcasting Private Limited (Director, since 13 Apr 2023); Annamraju Infra Private Limited (Director, since 05 Nov 2020).

Sreehari Kumar Annamraju was first appointed on 19 Nov 2019 as Managing Director at Citizenplus Pharmaceuticals Private Limited. The most recent appointment on record is 30 Sep 2025 at X Technology Private Limited.

Sreehari Kumar Annamraju held 1 earlier board appointment: Vani Pharma Labs Limited (Additional Director, 18 Aug 2023 to 04 Oct 2023).

The current boards of Sreehari Kumar Annamraju's companies include Venkata Radh Krishna Kishore Annamraju (Citizenplus Pharmaceuticals Private Limited), Aparna Annamaraju (X Technology Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available